Emerging evidence regarding the anti-cancer features of novel lipid-lowering treatments, including CETP inhibitors, bempedoic acid, and PCSK9 inhibitors
Emerging evidence regarding the anti-cancer features of novel lipid-lowering treatments, including CETP inhibitors, bempedoic acid, and PCSK9 inhibitors. (A). CETP inhibitors may confer anti-cancer effects by inhibiting the Wnt/β-Catenin signaling pathway and activating the JNK signaling pathway. The activation of JNK by CETP inhibition exhibits apoptotic activity, resulting in diminished tumorigenesis. Additionally, CETP inhibition may reduce tumorigenesis by dampening the activation of Wnt/β-Catenin. Specifically, CETP silencing has been associated with decreased activation of luciferase, reduced levels of the phosphorylated form of β-catenin (p-β-catenin (Ser675)), and lower levels of target genes involved in Wnt signaling, including axin2, cyclin D1, c-myc, and survivin. (B). Bempedoic acid has been suggested to possess anti-malignant properties through its ability to inhibit ACLY. SREBP1 promotes ACLY transcription, while the phosphorylation of Akt—mediated by both growth factors and glucose abundance—facilitates the enzyme’s acetylation and stabilization. ACLY activation leads to citrate deprivation, resulting in reduced tumorigenesis by enhancing the activation of the PI3K/Akt pathway. Interestingly, citrate deprivation is also linked to increased activity of regulatory enzymes in glycolysis, specifically PFK1 and PFK2. (C). PCSK9 silencing may exhibit anti-cancer properties by either reducing tumor cell proliferation or enhancing cancer cell apoptosis. PCSK9 inhibitors can facilitate apoptosis by increasing the activation of caspase-3 and downregulating anti-apoptotic proteins such as p-Akt and XIAP. Furthermore, PCSK9 inhibition may promote tumor cell apoptosis by interfering with mitochondrial signaling pathways. This interference is associated with an increased Bax/Bcl-2 ratio, leading to the elevated release of cytochrome-c. Abbreviations: ACLY, ATP citrate lyase; Akt, protein kinase B; BA, bempedoic acid; Bax, Bcl-2-associated X-protein; Bcl-2, B cell lymphoma-2; CETPi, cholesteryl ester transfer protein inhibitors; c-myc, cellular myc transcription factor; cyt-c, cytochrome-c; JNK, Jun N-terminal kinase; p-Akt, phosphorylated-Akt; PCSK9 i, proprotein convertase subtilisin/kexin type 9 inhibitor; PFK, phosphofructokinase; PI3K, phosphatidylinositol-3 kinase; SREBP1, sterol regulatory element-binding protein-1; Wnt, wingless-type MMTV integration site family; XIAP, X-linked inhibitor of apoptosis protein. Created with www.BioRender.com. (assessed on 14 July 2024)
Publication
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies (2024) Dimitris Kounatidis, et al. Metabolites. 2024 Jul;14(7). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CETP | CETP | ncbigene_symbol | CETP | 1071 |
| Homo sapiens | Primates | STOP | STOP | ncbigene_synonym | MAP6 | 4135 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT1 | 7471 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT2 | 7472 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT2B | 7482 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT3 | 7473 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT3A | 89780 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT4 | 54361 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT6 | 7475 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT7A | 7476 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT7B | 7477 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT8A | 7478 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT8B | 7479 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT9A | 7483 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT9B | 7484 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT10A | 80326 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT10B | 7480 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT11 | 7481 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT16 | 51384 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT5A | 7474 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT5B | 81029 |
| Homo sapiens | Primates | axin2 | AXIN2 | ncbigene_symbol | AXIN2 | 8313 |
| Homo sapiens | Primates | c-myc | C-MYC | ncbigene_synonym | MYC | 4609 |
| Homo sapiens | Primates | cyclinD1 | CCND1 | ncbigene_symbol | CCND1 | 595 |
| Homo sapiens | Primates | PCSK9 | PCSK9 | ncbigene_symbol | PCSK9 | 255738 |
| Homo sapiens | Primates | XIAP | XIAP | ncbigene_symbol | XIAP | 331 |
| Homo sapiens | Primates | p-Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | p-Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | p-Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | JNK | JNK | ncbigene_synonym | MAPK8 | 5599 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | Bax/Bcl-2 | BCL-2 | ncbigene_synonym | BCL2 | 596 |
| Homo sapiens | Primates | Bax/Bcl-2 | BAX | ncbigene_symbol | BAX | 581 |
| Homo sapiens | Primates | ACLY | ACLY | ncbigene_symbol | ACLY | 47 |
| Homo sapiens | Primates | SREBP1 | SREBP1 | ncbigene_synonym | SREBF1 | 6720 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | PFK1 | PFK1 | ncbigene_synonym | PFKM | 5213 |
| Homo sapiens | Primates | PFK2 | PFK2 | ncbigene_synonym | PFKFB3 | 5209 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| proteins | proteins | proteins | chebi:36080 | |
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|